0.0092
+0.0006
+(6.98%)
As of 10:06:21 AM GMT+2. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Tore Duvold | Chief Executive Officer | -- | -- | 1968 |
| Mr. Alexander Dahlquist | Part Time Chief Financial Officer | -- | -- | 1971 |
Spermosens AB
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 3
Description
Spermosens AB provides diagnostic health care products and services in Sweden. The company offers male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB was incorporated in 2018 and is based in Lund, Sweden.
Corporate Governance
Spermosens AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available